Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Rhone-Poulenc Rorer presents new taxane in phase I testing

May 25, 1998

Neuromedica receives patent for anticancer drug

May 25, 1998

Diatide's Theratide inhibits tumor growth

May 25, 1998

Maxamine in combination with IL-2 retards prostate tumor growth in rats

May 25, 1998

Suradista, a novel distamycin derivative in phase I testing at Pharmacia & Upjohn

May 22, 1998

Capecitabine clinical data and product introduction announced at ASCO

May 22, 1998

Techniclone evaluates VEGF as a tumor marker

May 22, 1998

Long-term prevention of precancerous colonic polyp formation demonstrated for FGN-1

May 22, 1998

Gd-Tex phase Ib/II interim results presented at ASCO

May 22, 1998

ONYX-015: phase I and II results in various cancers discussed at ASCO

May 21, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...